| [1] Boman H G,Nilsson I,Rasmuson B. Inducible antibacterial defence system in drosophila. Nature,1972,237(5352):232-235.
[2] Kim J K,Lee E,Shin S,et al. Structure and function of papiliocin with antimicrobial and anti-inflammatory activities isolated from the swallowtail butterfly,Papilio xuthus. J Biol Chem,2011,286(48):41296-41311.
[3] Bhargava K,Feix J B. Membrane binding,structure,and localization of cecropin-mellitin hybrid peptides:A site-directed spin-labeling study. Biophysical Journal,2004,86(1):329-336.
[4] Lee E,Jeong K W,Lee J,et al. Structure-activity relationships of cecropin-like peptides and their interactions with phospholipid membrane. BMB Reports,2013,46(5):282-287.
[5] Chen Y,Guarnieri M T,Vasil A I,et al. Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob Agents Chemother,2007,51(4):1398-1406.
[6] Park Y,Lee D G,Jang S H,et al. A Leu-Lys-rich antimicrobial peptide:activity and mechanism. Biochimica et Biophysica Acta,2003,1645(2):172-182.
[7] Sato H,Feix J B. Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity. Antimicrob Agents Chemother,2008,52(12):4463-4465.
[8] Chen H M,Wang W,Smith D,et al. Effects of the anti-bacterial peptide cecropin B and its analogs,cecropins B-1 and B-2,on liposomes,bacteria,and cancer cells. Biochimica et Biophysica Acta,1997,1336(2):171-179.
[9] Srisailam S,Kumar T K,Arunkumar A I,et al. Crumpled structure of the custom hydrophobic lytic peptide cecropin B3. European Journal of Biochemistry,2001,268(15):4278-4284.
[10] Wu J M,Jan P S,Yu H C,et al. Structure and function of a custom anticancer peptide,CB1a. Peptides,2009,30(5):839-848.
[11] Sung H H,Jane W N,Kao W Y,et al. Lipopolysaccharide-binding motif derived peptides induce cell membrane damages in human lung cancer and hepatoma cell lines. International Journal of Peptide Research & Therapeutics,2015,21(3):313-324.
[12] Boman H G. Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. Febs Letters,1989,259(1):103-106.
[13] Tian Z G,Dong T T,Teng D,et al. Design and characterization of novel hybrid peptides from LFB15(W4,10),HP(2-20),and cecropin A based on structure parameters by computer-aided method. Appl Microbiol Biotechnol,2009,82(6):1097-1103.
[14] Fox M A,Thwaite J E,Ulaeto D O,et al. Design and characterization of novel hybrid antimicrobial peptides based on cecropin A,LL-37 and magainin Ⅱ. Peptides,2012,33(2):197-205.
[15] Mathur P. Alpha,beta-dehydrophenylalanine containing cecropin-melittin hybrid peptides:conformation and activity. Journal of Peptide Science,2007,13(13):253-262.
[16] Morris C J,Beck K,Fox M A,et al. Pegylation of antimicrobial peptides maintains the active peptide conformation,model membrane interactions,and antimicrobial activity while improving lung tissue biocompatibility following airway delivery. Antimicrob Agents Chemother,2012,56(6):3298-3308.
[17] Díaz M D,De La Torre B G,Fernández-Reyes M,et al. Structural framework for the modulation of the activity of the hybrid antibiotic peptide Cecropin A-Melittin by Nε-Lysine trimethylation. ChemBioChem,2011,12(14):2177-2183.
[18] Shin S Y,Kang J H,Lee D G,et al. Influences of hinge region of a synthetic antimicrobial peptide,Cecropin A(1-13)-Melittin(1-13) hybrid on antibiotic activity. Bull Korean Chem Soc,1999,20(9):1078-1084.
[19] Schlamadinger D E,Wang Y,Mccammon J A,et al. Spectroscopic and computational study of melittin,cecropin A,and the hybrid peptide CM15. Journal of Physical Chemistry B,2012,116(35):10600-10608.
[20] Andreu D,Ubach J,Boman A,et al. Shortened cecropin A-melittin hybrids significant size reduction retains potent antibiotic activity. Febs Letters,1992,296(2):190-194.
[21] Maccari G,Di Luca M,Nifosi R,et al. Antimicrobial peptides design by evolutionary multiobjective optimization. PLoS Comput Biol,2013,9(9):e1003212.
[22] Ji S,Li W,Zhang L,et al. Cecropin A-melittin mutant with improved proteolytic stability and enhanced antimicrobial activity against bacteria and fungi associated with gastroenteritis in vitro. Biochemical & Biophysical Research Communications,2014,451(4):650-655.
[23] Zhang J,Li J,Movahedi A,et al. A novel inclusion complex(β-CD/ABP-dHC-cecropin A) with antibiotic propertiess for use as an anti-agrobacterium additive in transgenic poplar rooting medium. Enzyme & Microbial Technology,2015,81:72-79.
[24] 王晓波. 融合有酸性片段的天蚕素A-蜂毒素串联重复基因的构建和表达. 广州:暨南大学,2003. Wang X B. Construction and expression of tandem multi-copy gene edcoding CA(1-8)ME(1-10) hybrid fused acidic peptide. Guangzhou:Jinan University,2003.
[25] Zhang J,Movahedi A,Xu J,et al. In vitro production and antifungal activity of peptide ABP-dHC-cecropin A. Journal of Biotechnology,2015,199:147-154.
[26] 王炜,郑学礼,陈晓光. 应用伴侣分子在大肠杆菌表达系统高效表达家蝇天蚕素. 热带医学杂志,2009,9(2):128-131. Wang W,Zheng X L,Chen X G. High-level expression of Musca domestica cecropin with molecular partner in Escherichia coli. Journal of Tropical Medicine,2009,9(2):128-131.
[27] 王会岩,尹海燕,尹翌秋,等. 抗菌肽CM与血管内皮生长因子VEGF121在大肠杆菌中表达及鉴定. 吉林大学学报(医学版),2010,36(2):285-290. Wang H Y,Yin H Y,Yin Y Q,et al. Expression and identification of fusion protein of cecropin A-melittin and VEGF121 in E.coli. Journal of Jilin University(Medicine Edition),2010,36(2):285-290.
[28] 万一,沈卫荣,韩丽萍,等. 天蚕素B和表皮生长因子融合蛋白的原核表达、纯化与发酵. 中国生物制品学杂志,2009,22(11):1075-1079. Wan Y,Shen W R,Han L P,et al. Prokaryotic expression,purification and fermentation of cecropin B and epidermal growth factor fusion protein. Chin J Biologicals,2009,22(11):1075-1079.
[29] 卢雪梅,黄演婷,汪洁,等. 新型融合多肽HTPP-MDC体外抑制HBV复制活性及亚细胞定位. 中国病理生理杂志,2013,29(7):1283-1287. Lu X M,Huang Y T,Wang J,et al. HTPP-MDC inhibits replication and subcellular localization of hepatitis B virus in HepG2.2.15 cells. Chinese Journal of Pathophysiology,2013,29(7):1283-1287. |
